bcbs glp-1 BC/BS Health Insurance GLP 1 Change in Coverage GLP-1 Drugs: What Employers Need

This is because the primary and key secondary endpoints of this trial were limited to glycemic control and body weight reduction, with no assessment of cardiovascular outcomes that are used to define cardioprotection

The rise comes as more patients turn to these drugs for weight loss, including some who are using compounded or online versions without a prescription

Like all prescription medications, GLP-1s come with some risks and contraindications, which your Calibrate clinician will discuss with you to ensure safety and effectiveness

The evidence base for probiotics specifically marketed as "GLP-1 probiotics" for weight loss remains limited and preliminary

At Veracity, we believe that something designed to support your health should never quietly compromise it

On December 22, 2025 , the FDA approved the first oral GLP-1 medication specifically for obesity , the Wegovy pill from Novo Nordisk